关注
Ahmad Najafi
Ahmad Najafi
在 mazums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Analytical assessment of interleukin-23 and-27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a)
AA Hafez, AA Vasmehjani, R Baharlou, SDM Nasab, MH Davami, A Najafi, ...
Hepatitis monthly 14 (9), 2014
222014
Serological Study on Cytomegalovirus and Toxoplasma Gondii in Thalassemia Major Patients of Yazd, Iran
M Moghimi, M Doosti, A Najafi, M Shayestehpour
Iranian Journal of Pediatric Hematology Oncology 5 (3), 2014
222014
Effects of fennel, asafetida and ginseng ethanolic extracts on growth and proliferation of mouse breast cancer 4T1 cell lines
AH Mansourabadi, A Shams, R Mansouri, A Najafi, M Ajami
Advanced Herbal Medicine 1 (2), 34-39, 2015
112015
Green tea-mediated synthesis of silver nanoparticles: Enhanced anti-cancer activity and reduced cytotoxicity melanoma and normal murine cell lines
M Golpour, P Ebrahimnejad, ZR Gatabi, A Najafi, A Davoodi, R Khajavi, ...
Inorganic Chemistry Communications 161, 111989, 2024
22024
Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia
M Mohammadi, H Asgarian-Omran, B Najafi, A Najafi, R Valadan, ...
Iranian Journal of Immunology 20 (4), 438-445, 2023
12023
Expression of galectin-9-related immune checkpoint receptors in B-cell acute lymphoblastic leukemia
A Akbar, H Asgarian-Omran, R Valadan, MM Dindarloo, A Najafi, ...
Iranian Journal of Basic Medical Sciences 26 (12), 1468, 2023
12023
Effective delivery of anti-PD-L1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines
M Rajabinejad, R Valadan, M Tehrani, A Najafi, R Negarandeh, M Saeedi, ...
Medical Oncology 41 (6), 1-7, 2024
2024
Single domain antibodies specific for HER2 dimerization domain effectively disrupts HER2 dimerization
A Najafi, R Valadan, H Asgarian-Omran, A Rafiei, M Tehrani
International Immunopharmacology 124, 110999, 2023
2023
A seromolecular study to determine the prevalence of cytomegalovirus in pregnant women referred to health centers in the north of Iran
NM Saravi, F Aghajani, A Najafi, R Khajavi, Z Rahmani, H Jalali, ...
Iranian Journal of Microbiology 15 (4), 594, 2023
2023
Evaluation of mRNA Expression of CD244 and Its Adapter Molecules in CD8+ T Cells in Acute Leukemia
M Mohammadi, H Asgarian-Omran, A Najafi, R Valadan, H Karami, ...
Iranian biomedical journal 27 (4), 214, 2023
2023
The Association between Laboratory Biomarkers and Clinical Features in COVID-19 Pneumonia: as a Potential Tools for Prognostic and Severity of Disease
H Jalali, A Najafi, L Davoodi, A Alipour, MR Mahdavi
Research in Molecular Medicine 11 (1), 0-0, 2023
2023
Immune response evaluation after Sputnik V vaccination in Sari healthcare population
A Najafi, H Jalali, Y Noshi, M Mahdavi, MRM Amiri
The Journal of Medical Investigation 70 (3.4), 317-320, 2023
2023
Relative Expression of BATF and CD112 in PBMC of Patients with Chronic Lymphocytic Leukemia
A Najafi, M Sabaghi, H Asgarian-Omran, R Valadan, R Shekarriz, ...
Asian Pacific Journal of Cancer Prevention: APJCP 24 (6), 2171, 2023
2023
Genetic Polymorphisms of Cytotoxic T‐Lymphocyte Antigen 4 (CTLA‐4) and clinical outcomes post‐allogeneic hematopoietic stem cell transplantation: A systematic review and meta …
A Najafi, R Alizadeh‐Navaei, S Rahimi, R Valadan, M Tehrani
Clinical Transplantation 35 (8), e14364, 2021
2021
Comparison between interleukine-17 levels by NK-T cells in patients with chronic hepatitis C and healthy individuals
A Najafi, A Shams, A Ahmadi-Vasmehjani, SA Mirghanizadeh-bafghi, ...
Iranian Journal of Virology 8 (4), 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–15